P510: PREDICTORS OF RESPONSE AND OUTCOME IN PATIENTS WITH REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA RECEIVING VENETOCLAX WITH NON-INTENSIVE CHEMOTHERAPY

• Katja Krüger,
• Martin Wichmann,
• Razif Gabdoulline,
• Katharina Götze,
• Krischan Braitsch,
• Franziska Modemann,
• Walter Fiedler,
• Arne Trummer,
• Jürgen Krauter,
• Stephan Kaun,
• Susanne Rotermund,
• Andreas Voß,
• Gudrun Goehring,
• Yvonne Behrens,
• Felicitas Thol,
• Matthias Eder,
• Gernot Beutel,
• Michael Stadler,
• Michael Heuser,
• Rabia Shahswar

Affiliations

Katja Krüger

1 Hannover Medical School, Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover, Germany

Martin Wichmann

1 Hannover Medical School, Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover, Germany

Razif Gabdoulline

1 Hannover Medical School, Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover, Germany

Katharina Götze

2 Technical University of Munich (TUM), Klinikum rechts der Isar, Department of Medicine III, Munich, Germany

Krischan Braitsch

2 Technical University of Munich (TUM), Klinikum rechts der Isar, Department of Medicine III, Munich, Germany

Franziska Modemann

3 University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Department of Oncology, Hematology and Bone Marrow Transplantation, Hamburg, Germany

Walter Fiedler

3 University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Department of Oncology, Hematology and Bone Marrow Transplantation, Hamburg, Germany

Arne Trummer

5 Municipal Hospital Braunschweig, Department of Internal Medicine, Braunschweig, Germany

Jürgen Krauter

5 Municipal Hospital Braunschweig, Department of Internal Medicine, Braunschweig, Germany

Stephan Kaun

6 Municipal Hospital Bremen-Mitte, Department of Internal Medicine, Bremen, Germany

Susanne Rotermund

6 Municipal Hospital Bremen-Mitte, Department of Internal Medicine, Bremen, Germany

Andreas Voß

7 University Clinic Oldenburg, Department of Oncology and Hematology, Oldenburg, Germany

Gudrun Goehring

8 Hannover Medical School, Department of Human Genetics, Hannover

Yvonne Behrens

8 Hannover Medical School, Department of Human Genetics, Hannover

Felicitas Thol

1 Hannover Medical School, Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover, Germany

Matthias Eder

1 Hannover Medical School, Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover, Germany

Gernot Beutel

1 Hannover Medical School, Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover, Germany

Michael Stadler

1 Hannover Medical School, Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover, Germany

Michael Heuser

1 Hannover Medical School, Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover, Germany

Rabia Shahswar

1 Hannover Medical School, Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover, Germany